Login

Securities are offered through IFP Securities, LLC, while AmeriCorps' CEO shares key remarks in a separate discussion. 00:10:00

Share On Facebook Share On Twitter

William Hamm, CFA, CFP®, CLU. Chief Executive Officer 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Skeena Resources Highlights BC Mining Opportunities and Sustainability at Natural Resources Forum
00:10:00
Interview with Damien Canning | Alex Vaughan, CEO, Costain Group PLCCSGQF:PKC
00:10:00
Will Marshall of Planet Labs discusses how satellite images aid disaster relief efforts in a full episode |Will Marshall, co-founder & CEO of Planet Labs,
00:10:00
Tan Sri Dato' Seri Vincent Tan, Founder and Advisor of Berjaya Corporation Berhad, was named the 2023 Malaysia Real Estate Personality of the Year.|Tan Sri Dato' Seri Vincent Tanis the founder of Berjaya Corporation Berhad
00:10:00
Insights into Battery and EV Manufacturing: CEO Shares Vision | Somphote Ahunai, CEO, Energy Absolute PCL.
00:10:00
Luba Gozer Celebrates Women's Representation in Law and Corporate Boards
00:10:00
Redefining Energy: How Commodities, Branding, and Financing are Driving the Green Transition
00:10:00
Jonathan Kay on Media Coverage of Indigenous School Graves|Jonathan Kay,Professor,University of Massachusetts Medical School in Worcester
00:10:00
4GLOBAL focused on transition after "very good" 2022 | Eloy Mazon, CEO, 4Global PLC4GBL:LSE
00:10:00
A Vision for the Future in Pension Provision | Annette Mosman , CEO , APG.
00:00:00
Interview with CEO Jonathan Royce regarding restructuring program -Jonathan Royce Chief Executive Officer, Bio-Works Technologies
00:10:00
Exploring Retirement Plan Options: Simple IRAs and Roth Conversions | Adam Taylor, CEO, Taylor Financial.

© 2017 - Neuhu+